Advent Pharma Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 12, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	1,406	1,267	2,384	2,459	2,338	2,274
Market Cap Growth	2.72%	-46.88%	-3.03%	5.18%	2.82%	20.13%
Enterprise Value	1,483	1,338	2,456	2,530	2,392	2,285
Last Close Price	15.10	13.55	25.34	25.90	24.41	23.56
PE Ratio	29.10	18.94	28.39	24.93	23.97	20.02
PS Ratio	3.07	2.53	4.17	4.41	4.41	4.51
PB Ratio	0.90	0.83	1.62	1.76	1.78	1.84
P/TBV Ratio	0.90	0.83	1.62	1.76	1.78	1.84
P/FCF Ratio	5582.41	61.59	182.32	958.68	-	-
P/OCF Ratio	32.97	11.04	13.61	11.98	13.02	12.60
EV/Sales Ratio	3.24	2.67	4.30	4.53	4.51	4.54
EV/EBITDA Ratio	11.01	8.46	11.83	13.05	13.66	13.09
EV/EBIT Ratio	20.70	13.99	17.34	18.69	17.93	16.75
EV/FCF Ratio	5887.09	65.04	187.80	986.61	-	-
Debt / Equity Ratio	0.05	0.05	0.05	0.05	0.05	0.05
Debt / EBITDA Ratio	0.58	0.48	0.37	0.37	0.36	0.34
Debt / FCF Ratio	308.24	3.69	5.81	27.92	-	-
Net Debt / Equity Ratio	0.05	0.05	0.05	0.05	0.05	0.01
Net Debt / EBITDA Ratio	0.57	0.47	0.35	0.36	0.34	0.10
Net Debt / FCF Ratio	304.68	3.60	5.51	27.50	-5.16	-4.69
Asset Turnover	0.24	0.26	0.31	0.33	0.34	0.35
Inventory Turnover	4.17	4.87	4.68	4.16	3.96	4.01
Quick Ratio	1.27	1.01	0.78	0.62	0.71	1.03
Current Ratio	1.81	1.51	1.28	1.15	1.38	1.72
Return on Equity (ROE)	3.13%	4.46%	5.85%	7.27%	7.66%	9.65%
Return on Assets (ROA)	2.30%	3.15%	4.86%	4.93%	5.27%	5.90%
Return on Invested Capital (ROIC)	3.41%	4.71%	7.61%	7.30%	7.61%	9.73%
Return on Capital Employed (ROCE)	4.00%	5.50%	8.50%	8.60%	9.00%	10.00%
Earnings Yield	3.42%	5.28%	3.52%	4.01%	4.17%	5.00%
FCF Yield	0.02%	1.62%	0.55%	0.10%	-0.49%	-0.16%
Dividend Yield	0.32%	0.37%	0.40%	0.77%	0.82%	0.83%
Payout Ratio	4.29%	22.06%	9.76%	8.93%	22.79%	7.11%
Total Shareholder Return	0.94%	0.37%	0.40%	0.77%	0.82%	0.83%